Deploying capital into Greater China real assets and growth-stage technology, Yiheng Capital Management targets cross-border co-investments and control and minority stakes across real estate, logistics, renewable energy, and SaaS platforms. The firm combines balance-sheet financing with structured equity to support operational scale-ups and asset-light rollups for institutional and family-office clients. Portfolio activity emphasizes cash-flow generation, asset optimization, and follow-on capital for winners; fundraising and exits leverage strategic corporate partnerships and domestic secondary channels. Investment team experience spans private equity, asset management, and project finance, with allocation discipline toward ESG-aligned infrastructure and recurring-revenue businesses that offer resilient return profiles.
Deploying capital into Greater China real assets and growth-stage technology, Yiheng Capital Management targets cross-border co-investments and control and minority stakes across real estate, logistics, renewable energy, and SaaS platforms. The firm combines balance-sheet financing with structured equity to support operational scale-ups and asset-light rollups for institutional and family-office clients. Portfolio activity emphasizes cash-flow generation, asset optimization, and follow-on capital for winners; fundraising and exits leverage strategic corporate partnerships and domestic secondary channels. Investment team experience spans private equity, asset management, and project finance, with allocation discipline toward ESG-aligned infrastructure and recurring-revenue businesses that offer resilient return profiles.
Focuses on Greater China real assets and growth-stage technology, deploying balance-sheet financing and structured equity into cross-border co‑investments and both control and minority stakes across real estate, logistics, renewable energy and SaaS. The firm prioritizes cash‑flow generation, asset optimization and asset‑light rollups, underwriting with a bias toward ESG‑aligned infrastructure and recurring‑revenue models. Capital allocation mixes strategic direct investments, follow‑on reserves and partner-led exits to deliver resilient returns for institutional and family‑office clients, leveraging project finance expertise and domestic secondary channels.
Focuses on Greater China real assets and growth-stage technology, deploying balance-sheet financing and structured equity into cross-border co‑investments and both control and minority stakes across real estate, logistics, renewable energy and SaaS. The firm prioritizes cash‑flow generation, asset optimization and asset‑light rollups, underwriting with a bias toward ESG‑aligned infrastructure and recurring‑revenue models. Capital allocation mixes strategic direct investments, follow‑on reserves and partner-led exits to deliver resilient returns for institutional and family‑office clients, leveraging project finance expertise and domestic secondary channels.
| Trades 492 | Longs Won 257/492 52% | Profit Factor 1.64 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $16.69M |
| Average Win $6.24M | Best Trade (Sep 30) $303.67M | Sharpe Ratio -11.39 |
| Average Loss -$4.15M | Worst Trade (Sep 30) -$61.3M | Z-Score -1.99 (98.49%) |
| Commissions $0 | Avg. Trade Length 2y 4m 2w 2d | Expectancy $1.27M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 1.06% | 4.17% | 9.28% | 16.38% | 25.45% | 36.48% | 49.45% | 64.37% | 81.22% |
| Consecutive Losing Trades | 54 | 49 | 43 | 38 | 32 | 27 | 22 | 16 | 11 | 5 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
API Agora Inc. | 725,795 | $2.75M | $3.37M | - | $613,874.72 | 22.29% | -3.934% |
BEAM Beam Therapeutics Inc. | 21,126 | $575,049.72 | $565,120.5 | - | -$9,929.22 | -1.73% | +0.905% |
BILI Bilibili Inc. | 1.49M | $21.78M | $25.98M | - | $4.21M | 19.32% | +2.168% |
BILL Bill Holdings Inc. | 222,820 | $8.53M | $11.09M | - | $2.56M | 29.97% | -2.982% |
BIOA BioAge Labs, Inc. | 170,532 | $4.18M | $1.81M | - | -$2.37M | -56.75% | +1.63% |
DBVT Dbv Technologies S.A. Sponsored ADR | 170,142 | $525,738.83 | $2.39M | - | $1.86M | 353.72% | -0.071% |
EDU New Oriental Education & Technology Group Inc. | 1,636 | $92,646.68 | $85,955.44 | - | -$6,691.24 | -7.22% | +0.401% |
HNGE Hinge Health Inc. | 156,190 | $6.02M | $13.83M | - | $7.81M | 129.64% | +1.293% |
HTHT H World Group Limited American Depositary Receipt | 323,371 | $10.15M | $13.54M | - | $3.39M | 33.41% | +3.382% |
JD JD.com Inc. | 590,513 | $16.78M | $17.17M | - | $389,997.08 | 2.32% | -0.785% |
JOYY JOYY Inc. American Depositary Shares | 85,583 | $5M | $6.25M | - | $1.25M | 25.06% | +1.178% |
KYMR Kymera Therapeutics Inc. | 63,440 | $1.74M | $7.45M | - | $5.71M | 328.9% | +2.596% |
NOAH Noah Holdings Ltd. | 6.72M | $214.74M | $57.97M | - | -$156.77M | -73% | +0.232% |
PASG Passage Bio Inc. | 86,097 | $811,350.33 | $395,185.23 | - | -$416,165.1 | -51.29% | +0.328% |
PONY Pony AI Inc. | 653,215 | $11.07M | $5.31M | - | -$5.76M | -52.04% | -2.401% |
PSIX Power Solutions International, Inc. | 133,500 | $4.87M | $5.41M | - | $544,680 | 11.19% | -1.29% |
RERE Atrenew Inc. | 3.16M | $9M | $14.39M | - | $5.39M | 59.96% | -1.087% |
SVCO Silvaco Group, Inc. | 906,381 | $4.13M | $6.58M | - | $2.45M | 59.21% | -1.626% |
TAL Tal Education Group | 759,240 | $8.47M | $8.85M | - | $378,600.49 | 4.47% | +0.431% |
TCOM Trip.com Group Limited American Depositary Receipt | 88,112 | $4.39M | $3.96M | - | -$423,818.24 | -9.66% | -0.089% |